Billionaire Dilip Shanghvi gets US boost, Sun Pharma share price jumps 4%; but should you buy?

Sun Pharma has received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at the Halol facility during the period February 12-23, 2018, Sun Pharma said in a filing to BSE.

Billionaire Dilip Shanghvi gets US boost, Sun Pharma
Sun Pharma share price gained as much as 3.74 per cent to Rs 560.75. Image source: Reuters

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x